MILLENNIUM MANAGEMENT LLC - PACIFIC BIOSCIENCES CALIF IN ownership

PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 247 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of PACIFIC BIOSCIENCES CALIF IN
ValueSharesWeighting
Q3 2023$4,750,457
-74.5%
568,917
-59.5%
0.00%
-70.0%
Q2 2023$18,664,967
+800627.9%
1,403,381
+597.2%
0.01%
+900.0%
Q1 2023$2,331
-59.3%
201,300
-71.2%
0.00%
-66.7%
Q4 2022$5,725
-99.9%
699,888
-8.2%
0.00%0.0%
Q3 2022$4,427,000
+273.9%
762,627
+184.6%
0.00%
+200.0%
Q2 2022$1,184,000
-95.1%
267,969
-89.8%
0.00%
-92.3%
Q1 2022$23,996,000
+126.2%
2,636,902
+408.7%
0.01%
+116.7%
Q4 2021$10,607,000
+6.6%
518,404
+33.2%
0.01%0.0%
Q3 2021$9,946,000
-62.9%
389,280
-49.2%
0.01%
-62.5%
Q2 2021$26,822,000
+81.9%
767,005
+73.3%
0.02%
+60.0%
Q1 2021$14,744,000
-66.1%
442,633
-73.6%
0.01%
-68.8%
Q4 2020$43,465,000
+103.6%
1,675,584
-22.5%
0.03%
+23.1%
Q3 2020$21,347,000
+204.0%
2,162,865
+6.3%
0.03%
+160.0%
Q2 2020$7,022,000
-2.4%
2,035,463
-13.4%
0.01%
-37.5%
Q1 2020$7,195,000
-44.9%
2,351,297
-7.5%
0.02%0.0%
Q4 2019$13,059,000
+34.0%
2,540,590
+34.5%
0.02%
+6.7%
Q3 2019$9,746,000
+147.9%
1,888,900
+190.7%
0.02%
+150.0%
Q2 2019$3,931,000
-80.1%
649,700
-76.2%
0.01%
-80.0%
Q1 2019$19,741,000
+0.1%
2,730,462
+2.4%
0.03%
-3.2%
Q4 2018$19,729,000
+1031.2%
2,666,088
+727.2%
0.03%
+1450.0%
Q3 2018$1,744,000
+42.7%
322,315
-6.4%
0.00%0.0%
Q2 2018$1,222,000
+105.7%
344,194
+18.9%
0.00%
+100.0%
Q1 2018$594,000
+78.9%
289,523
+130.2%
0.00%
Q4 2017$332,000
-93.4%
125,756
-86.9%
0.00%
-100.0%
Q3 2017$5,052,000
+197.5%
962,221
+101.8%
0.01%
+166.7%
Q2 2017$1,698,000
+1897.6%
476,846
+2812.6%
0.00%
Q1 2017$85,000
-97.6%
16,372
-98.3%
0.00%
-100.0%
Q4 2016$3,597,000
-49.3%
946,545
+19.5%
0.01%
-33.3%
Q3 2016$7,096,000
-72.1%
791,975
-78.1%
0.01%
-79.3%
Q2 2016$25,412,000
-15.1%
3,612,194
+2.6%
0.06%
-22.7%
Q1 2016$29,929,000
+385.2%
3,521,027
+649.5%
0.08%
+476.9%
Q4 2015$6,168,000
-41.8%
469,789
-83.8%
0.01%
-38.1%
Q3 2015$10,598,000
-46.6%
2,895,705
-15.9%
0.02%
-44.7%
Q2 2015$19,840,000
+56.6%
3,444,467
+58.8%
0.04%
+58.3%
Q1 2015$12,666,000
-25.4%
2,168,907
+0.1%
0.02%
-33.3%
Q4 2014$16,989,000
+83.8%
2,167,018
+15.1%
0.04%
+56.5%
Q3 2014$9,242,000
-48.2%
1,882,280
-34.8%
0.02%
-53.1%
Q2 2014$17,852,000
-0.5%
2,888,724
-13.9%
0.05%
-5.8%
Q1 2014$17,941,000
+40.2%
3,353,536
+37.1%
0.05%
+30.0%
Q4 2013$12,793,000
+9.7%
2,446,147
+15.7%
0.04%
+5.3%
Q3 2013$11,666,000
+946.3%
2,113,434
+379.8%
0.04%
+1166.7%
Q2 2013$1,115,000440,5170.00%
Other shareholders
PACIFIC BIOSCIENCES CALIF IN shareholders Q1 2022
NameSharesValueWeighting ↓
Madrone Advisors, LLC 16,415,933$137,073,04129.47%
ORACLE INVESTMENT MANAGEMENT INC 1,638,395$13,680,5984.20%
Decheng Capital Management III (Cayman), LLC 1,463,872$12,223,3314.08%
VK Services, LLC 2,632,784$21,983,7462.93%
Iron Triangle Partners LP 1,800,000$15,030,0002.20%
BOURNE LENT ASSET MANAGEMENT INC 574,350$4,795,8222.11%
Deep Track Capital, LP 6,000,000$50,100,0001.93%
Jackson Square Partners, LLC 6,933,865$57,897,7731.93%
ARK Investment Management 29,822,440$249,017,3701.90%
Nikko Asset Management Americas, Inc. 13,447,666$112,153,5341.34%
View complete list of PACIFIC BIOSCIENCES CALIF IN shareholders